Author

Marta Piñeiro-Sotelo

Observed name: Piñeiro-Sotelo, Marta

ORCID: 0009-0006-1192-0816

Observed ORCID: 0009-0006-1192-0816

OpenAlex ID: A5043061324

Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

2024 · Sonia Ares-Gómez, Narmeen Mallah, et al. · The Lancet Infectious Diseases · 289

Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis

2025 · Niklas Dyrby Johansen, Daniel Modin, et al. · The Lancet · 57

High-Dose Influenza Vaccine to Reduce Hospitalizations

2025 · Jacobo Pardo-Seco, Carmen Rodríguez-Tenreiro-Sánchez, et al. · New England Journal of Medicine · 56

Full 2023–24 season results of universal prophylaxis with nirsevimab in Galicia, Spain: the NIRSE-GAL study

2024 · Narmeen Mallah, Jacobo Pardo-Seco, et al. · The Lancet Infectious Diseases · 55

Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study

2026 · Josefina L Razzini, Iago Giné-Vázquez, et al. · The Lancet Infectious Diseases · 43

High-Dose Versus Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis

2025 · Niklas Dyrby Johansen, Daniel Modin, et al. · Circulation · 20

Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

2024 · Narmeen Mallah, Sonia Ares-Gómez, et al. · Human Vaccines & Immunotherapeutics · 20

Respiratory syncytial virus–related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL study

2025 · Angela Manzanares, Jacobo Pardo-Seco, et al. · European Journal of Pediatrics · 13

PDF

Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons

2023 · Sonia Ares-Gomez, Narmeen Mallah, et al. · Archivos de Bronconeumología · 4

Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults

2026 · Mats C. H. Lassen, Sine H. Christensen, et al. · NEJM Evidence · 3

Methods and operational framework of GALFLU: Individually randomized pragmatic controlled trial of high- versus standard-dose influenza vaccination in older adults

2026 · Narmeen Mallah, Jacobo Pardo-Seco, et al. · Vaccine · 2

High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease

2026 · Manan Pareek, Niklas Dyrby Johansen, et al. · Journal of the American College of Cardiology · 2

High-dose vs standard-dose influenza vaccine in heart failure: the FLUNITY-HD pooled analysis

2026 · Niklas Dyrby Johansen, Daniel Modin, et al. · European Heart Journal · 1

Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccine in Older Adults with Chronic Lung Disease: A Prespecified Analysis of the FLUNITY-HD Study

2026 · Lisa Steen Duus, Niklas Dyrby Johansen, et al. · European Respiratory Journal

RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial

2026 · Kristoffer Grundtvig Skaarup, Mats C H Lassen, et al. · European Journal of Heart Failure

Risk of Myocarditis and Pericarditis With Bivalent RSV Prefusion F Protein-Based Vaccine

2026 · Marat Yafasov, Mats C. Højbjerg Lassen, et al. · Journal of the American College of Cardiology

Effectiveness of Bivalent RSV Prefusion F Protein–Based Vaccine in Individuals With and Without Atrial Fibrillation

2026 · Caroline Espersen, Mats C. Højbjerg Lassen, et al. · Journal of the American College of Cardiology

A Bayesian Re-analysis of the GALFLU Trial of High-Dose vs Standard-Dose Influenza Vaccine Against Hospitalization Outcomes

2026 · Jacobo Pardo-Seco, Carmen Rodriguez-Tenreiro-Sánchez, et al. · Clinical Infectious Diseases

TOP-049 Pooling strategies for age-based hepatitis C screening in Spain: population impact and cost-effectiveness to inform national policy

2026 · A. Aguilera, Raquel Carracedo, et al. · Journal of Hepatology

Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD)

2026 · Najwa Ejje, Niklas Dyrby Johansen, et al. · Australian and New Zealand Journal of Public Health

Opportunistic age-based hepatitis C screening pooling for HCV-RNA testing: a cost-effectiveness analysis

2026 · Antonio Aguilera, Raquel Carracedo, et al. · Revista Española de Enfermedades Digestivas

WED-513 Automatic opportunistic age screening for hepatitis C virus. A public health strategy in Galicia, Spain. Project 2023

2024 · Elena Cruz-Ferro, Susana Miras-Carballal, et al. · Journal of Hepatology

Works count: 23

Citation count: 565

H-index: 8

I10-index: 8